Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

NZX falls as Synlait and Mainfreight take hits
Markets Market Close

NZX falls as Synlait and Mainfreight take hits

Market reacts strongly to news of "challenges" at Synlait's Dunsandel plant.

Tom Raynel 30 Jul 2025
'Slow and disappointing' start to the year for Mainfreight
Markets

'Slow and disappointing' start to the year for Mainfreight

The freight and logistics firm said profits were down across its three main divisions.

Staff reporters 30 Jul 2025
Ryman toils to rebuild shareholder confidence
Property

Ryman toils to rebuild shareholder confidence

"When is the total board going to resign?" asked one shareholder.

Gregor Thompson 30 Jul 2025
Synlait shares slump 11% even as outlook brightens
Primary Sector

Synlait shares slump 11% even as outlook brightens

The market is disappointed about manufacturing challenges. 

Rebecca Howard 30 Jul 2025